5 The agency reiterated the fact that Medicare Part D cannot cover medications used for weight management
SURMOUNT-1 data: 2.5 mg tirzepatide: 8.1% headache rate 5 mg: 9.4% 10 mg: 10.2% 15 mg: 10.9% The increase is not dramatic, but the pattern is consistent
However, these drugs are associated with a wide array of side effects, and some say alternatives are needed
I am feeling lean and so good
IGF-1 levels decline toward baseline
People who may be at higher risk include: People experiencing rapid or significant weight loss Those taking higher-dose GLP-1 medicines, particularly semaglutide or tirzepatide Women, who reported hair loss more often in current studies People with low protein intake or deficiencies in iron, zinc, vitamin D, and B vitamins Individuals with existing nutritional deficiencies or other conditions that affect hair growth What to Expect if Hair Loss Occurs After Starting GLP-1 Drugs Can Hair Loss Be Prevented While Taking GLP-1 Drugs